In the title compound, C 26 H 30 ClN 5 OÁCHCl 3 , the purine molecule consists of essentially planar benzene and purine ring systems [maximum deviation 0.010 (4) Å for both ring systems] forming a dihedral angle of 85.52 (9) . Intermolecular N-HÁ Á ÁN hydrogen bonds link adjacent molecules into centrosymmetric dimers. The structure also contains intermolecular C-HÁ Á ÁO and C-HÁ Á ÁN interactions. The benzene rings form offset face-to-face -stacking interactions with an interplanar distance of 3.541 (4) Å and a centroid-to-centroid distance of 4.022 (4) Å .
Related literature
The title compound was prepared according to a modified literature procedure (Fiorini & Abel, 1998) . For the synthesis and/or biological activity of related compounds, see: Legraverend & Grierson (2006) ; Long et al. (2007) Table 1 Hydrogen-bond geometry (Å , ). (1-Adamantyl){4-[(2-chloro-9-isopropyl-9H-purin-6-yl)aminomethyl]phenyl}methanone trichloromethane solvate M. Rouchal, M. Necas and R. Vícha
Comment
Purine molecules substituted at C2, C6 and N9 are known as potential ATP-competitive inhibitors of cyclin-dependent kinases (key regulators of the cell division cycle) and due to this fact, they can show an anticancer activity (Legraverend & Grierson, 2006) . The adamantane scaffold is often used in order to improve the biological properties of potential or known drugs and a number of compounds with various biological activity have been described, e.g. antitumor agents published by Long et al. (2007) .
The asymmetric unit of the title compound ( (Table 2) include C23-H23A···O1, C5-H5B···N3, C-H···Cl contacts and offset face-to-face π-π interactions with an interplanar distance of 3.541 (4) Å and a centroid-centroid distance of 4.022 (4) Å.
Experimental
The title compound was prepared according to a slightly modified literature procedure (Fiorini & Abel, 1998 ). 2,6-Dichloro-9-(propan-2-yl)-9H-purine (0.53 mmol, 122.5 mg) and (1-adamantyl)-[4-(aminomethyl)phenyl]methanone hydrochloride (0.56 mmol, 170 mg) were dissolved in a mixture of DMF (2 ml) and triethylamine (1.06 mmol, 0.15 ml). The resulting solution was stirred under reflux for 2 h (the reaction progress was monitored by TLC). After this period, the mixture was diluted with water and extracted five times with 15 ml of diethyl ether. The combined organic layers were washed twice with brine and dried over sodium sulfate. The desired product was obtained by evaporation of the solvent in vacuum and purified by column chromatography (silica gel; petroleum ether/ethyl acetate, v/v 1:1) to give a colourless crystalline powder (210 mg, 86%, mp 190-192°C) . The crystal used for data collection was acquired by evaporation from a chloroform solution at room temperature.
Figures Fig. 1 . The molecular structure with displacement ellipsoids drawn at 50% probability for non-H atoms.
supplementary materials sup-2 . Displacement ellipsoids are drawn at 50% probability for non-H atoms.
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